Sales Strategy for Medical Device Companies: Coverage Before Pitch

Sales Strategy for Medical Device Companies: Coverage Before Pitch

Picture a device company with a newly cleared product and fresh funding that hires six direct reps, gives each a region and a quota, and sends them out. Three months later two of them have still not been inside the hospitals that matter most, because their credentials at those facilities lapsed and nobody at the company was tracking it. A third has a surgeon who loves the product and a hospital that buys through a group contract the company is not on. The pitch was never the problem. The coverage, the access and the contract were.

This page is for the medical device company planning its own field sales: the chief commercial officer, the sales vice president or the founder deciding how the product gets carried into facilities. The regulatory gate, the buying committee and the evidence question are already set out in medical device go-to-market strategy, and the committee is not described again here. Companies selling services to device makers want cold email for medical devices. What follows is the field layer: who carries the product, how a rep gets through the door, which contract the hospital buys on, and the calendar and conduct rules around all three. Sources were fetched on 18 September 2026.

Four ways to carry a device into the field

The clearest map of the options is an old one, and it is cited here as such. Writing in MD+DI on 1 September 2008, John C. Zimmer reviewed four common sales force structures for a medtech company: direct reps, independent reps, dealers and distributors, and hybrid models, with the right choice depending on the company's size, available cash, sales objectives and need to establish market share.

Direct reps are employees who sell only the company's products, hold an exclusive territory and report to a sales manager. Zimmer calls a dedicated force a luxury that comes at a cost, and wrote that adequately staffing one with specialists was prohibitive for all but large companies because the fixed costs are too high and carry no performance guarantee. Independent reps are self-employed, work on straight commission, carry their own expenses and typically represent five to eight complementary product lines, giving their time to the lines that pay the most for the least effort. Their territories are often larger than a direct rep's. Dealers and distributors buy products for resale and take ownership of them, including shipping, billing and collections, and commonly handle hundreds of lines, some of which compete. His two concerns about selling only through them are the lack of selling time any one person gives any one line, and non-exclusivity.

His figures are from 2008 and are not repeated as current. The structure is what lasts. One of his observations explains why the choice matters to most of the industry: citing the Dun and Bradstreet database at the time, Zimmer wrote that only 4 percent of medtech companies had annual sales of 50 million dollars or more.

Access is a gate the sales plan has to staff

RepMove, a vendor of rep software, described the work on 5 September 2025 as a business-to-business, field sales-based industry in which reps meet face to face at hospitals, clinics and surgical centers, and split it into capital equipment, disposables, and the more specialised categories of implants and diagnostics. Face to face means getting into the building, and the buildings have rules.

GHX, which runs a credentialing service, wrote on 29 August 2023 that hospital vendor credentialing requirements have grown in scope and complexity, that they can vary from facility to facility even within the same health system, and that there is no standard set. Essentially anyone not employed by the hospital who represents an outside organisation needs credentialing, it says, and denial of access can mean lost business opportunities and revenue. The hospitals say the same thing more bluntly. Ballad Health's vendor page states that demonstration of products by vendor representatives at any of its facilities is a privilege, not a right, that non-compliance will result in financial penalty or suspension of privileges at all locations, that it works through the vendor management agency symplr, and that it will not remind a rep of upcoming expirations. UC Davis Health runs a Vendor Access Program to monitor on-site visits, and expects suppliers to know and adhere to the rules of each unit they wish to visit.

For a sales strategy this is a staffing line. Somebody owns credentials for every rep at every facility, and a rep's real territory is the set of facilities where they are current.

The contract the hospital buys on

The Healthcare Supply Chain Association, the trade body for group purchasing organisations, explains the mechanism in its own FAQ. A group purchasing organisation aggregates the purchasing volume of hospitals, nursing homes, surgery centers and clinics and negotiates contracts with manufacturers and distributors. It does not purchase anything: after a contract is created it is still up to the hospital to decide which product is appropriate and to make the purchase. Most providers make group purchasing selections in a committee of doctors, nurses and other clinicians. The organisations are financed in part by administrative fees paid by vendors, and the FAQ cites a 2010 Government Accountability Office report that put the average weighted fee between 1.22 and 2.25 percent.

SPOTIO, another field sales software vendor, wrote on 13 July 2026 that generic customer profiles do not work in medtech, that the addressable market should be segmented into hospitals and integrated delivery networks, ambulatory surgery centers, physician offices and outpatient clinics, and that a value analysis committee, not a single physician, decides which products get approved. The strategic consequence is that the account list carries the contract: which group purchasing organisation each facility uses and whether the company is on it. How the committee itself works is in the go-to-market page linked above, and how to build the target list around it is in medical device lead generation.

The calendar: fiscal years and the disclosure cycle

Hospital finance leaders answered the fiscal year question in a forum published by the Healthcare Financial Management Association. David A. Williams, a partner at Horne LLP, wrote that most not-for-profit and for-profit hospitals have calendar years while most state, local government or hospital-district hospitals traditionally have a June or September year-end. Robert J. Ellertsen, an interim chief financial officer in Massachusetts, wrote that nearly all of that state's not-for-profit acute care hospitals have a 30 September year-end. Marty Knutson, a health lawyer, described the end-of-year nuttiness that a calendar fiscal year adds to December. A capital equipment plan that treats every hospital as closing its budget in December is wrong for public hospitals and for a whole state.

The second calendar is the government's. The Centers for Medicare and Medicaid Services describes Open Payments as a national disclosure programme with a publicly accessible database of payments that reporting entities, including medical device companies, make to covered recipients like physicians. Companies collect data from 1 January to 31 December, submit it between 1 February and 31 March, covered recipients review and dispute from 1 April to 15 May, corrections run to 30 May, and publication is on or by 30 June. The programme year 2025 data holds 17.07 million published records.

The rules that shape what a rep may do

Three sets of rules reach rep conduct. Open Payments makes what a company gives a physician public, and CMS notes that it does not comment on which relationships may be beneficial or a conflict of interest; it publishes the data and leaves interpretation open. The AdvaMed Code of Ethics gives medical technology companies guidance on interactions and relationships with health care professionals, strongly encourages a company that adopts it to submit a biennial certification that it has an effective compliance programme, and carries revisions effective 1 November 2025 on handling data responsibly. And each facility has its own policy: UC Davis Health says its vendor relations policy exists to reduce the potential for industry influence on providers' decisions and points vendors to its gifts policy.

For written outreach to administrators and supply chain staff, the Federal Trade Commission's CAN-SPAM guide says the Act makes no exception for business-to-business email and requires accurate header information, subject lines that are not deceptive, a valid physical postal address and an opt-out honoured within 10 business days. None of this is legal advice.

Channel reality, and when each model is the wrong play

This vertical sells in person, and its own sources say so. Our own motion is email and LinkedIn, one message per campaign and no bump sequences, and in medical devices its honest use is narrow: opening conversations with supply chain, value analysis and administrative contacts who work at a desk, and with distributors and independent rep groups a manufacturer wants to recruit. It does not replace the rep in the procedure room, and we do not claim it does.

Three openers, for the desks a message can reach

Each rests on one fetched source. The companies and facts in them are invented for illustration, and none claims a result.

Writing the plan

Choose the coverage model by segment and region, from what the volume can pay for. Give credentials an owner and count a rep's territory as the facilities where they are current. Put the group purchasing contract and the fiscal year-end on every account record. Train reps on the company's adopted code and on what becomes public in June each year. The general planning worksheet is the sales strategy template.

If the constraint is opening conversations with supply chain and administrative buyers, or recruiting distribution, RevenueFlow books qualified meetings on a pay-per-meeting basis, by email and LinkedIn, with the qualification criteria agreed in writing before launch.

Sales force structures per John C. Zimmer in MD+DI, 1 September 2008; field description per RepMove, 5 September 2025; segmentation per SPOTIO, 13 July 2026; credentialing per GHX, 29 August 2023, Ballad Health and UC Davis Health; group purchasing per the Healthcare Supply Chain Association FAQ; fiscal years per the HFMA forum; disclosure per CMS Open Payments; conduct guidance per AdvaMed; email rules per the FTC's CAN-SPAM guide. All fetched 18 September 2026.

Sources: Sales Force Strategies for a Competitive Advantage, MD+DI, Medical Device Sales Playbook, RepMove, Medical Device Sales Strategies, SPOTIO, Vendor Credentialing in Hospitals, GHX, Vendors, Ballad Health, Vendor Credentialing, UC Davis Health, FAQ, Healthcare Supply Chain Association, Hospital Fiscal Year Forum, HFMA, Open Payments, CMS, AdvaMed Code of Ethics, CAN-SPAM Act Compliance Guide, FTC